The president issued an executive order increasing research into drugs used to treat PTSD and other disorders.
President Trump directed his administration to fast-track reviews of certain psychedelic drugs, including ibogaine, which has ...
Trump ordered faster approval of ibogaine for PTSD, backing research and funding that could expand access to ...
Morning Overview on MSN
Trump signs order to fast-track reviews of psychedelics like ibogaine
Thousands of American veterans struggling with PTSD, opioid addiction, and traumatic brain injuries may soon have a new ...
President Trump has signed an executive order to make certain psychedelic drugs more available to treat mental health ...
Trump has ordered a fast-track review of psychedelic drugs, including ibogaine, to explore their potential in treating mental ...
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.
President Donald Trump was surprised to read on Saturday, during the announcement of an executive order fast-tracking ...
Flanked by Health and Human Services Secretary Robert F. Kennedy Jr., FDA Commissioner Marty Makary, and high-profile ...
4d
Opna Bio Announces Fast Track Designation Granted to OPN-6602 for the Treatment of Multiple Myeloma
OPN-6602 Currently Treating Patients in Phase 1 Clinical Trial SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 15, 2026-- Opna Bio, a clinical-s ...
The FDA has granted fast track designation to OPN-6602, an investigational oral dual inhibitor of EP300 and CREB-binding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results